{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-003091","form_type":"8-K","ticker":"OCEA","cik":"0001869974","company_name":"Ocean Biomedical, Inc.","filed_at":"2024-01-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.173093+00:00","generated_at":"2026-06-06T21:28:33.207210+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Ocean Biomedical notified by Nasdaq of MVLS below $35M minimum; 180 days to regain compliance","bullets":["Nasdaq notified Ocean Biomedical on Jan 17, 2024 that its MVLS was below $35M minimum for 30 consecutive business days.","Company has until July 15, 2024 to regain compliance; MVLS must close at $35M+ for 10 consecutive business days.","If not compliant by July 15, Nasdaq may delist; company can appeal to a Hearings Panel.","No immediate effect on trading; stock continues trading under symbol OCEA."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-003091","json":"https://secwatch.observer/filing/0001493152-24-003091.json","markdown":"https://secwatch.observer/filing/0001493152-24-003091.md","text":"https://secwatch.observer/filing/0001493152-24-003091.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1869974/000149315224003091/0001493152-24-003091-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1869974/000149315224003091/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T21:28:33.207210+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6fdf2f213fffffd6c523bf6302fee72865737b76","claim":"Ocean Biomedical, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).","evidence_excerpt":"January 17, 2024, Ocean Biomedical, Inc. (the “ Company ”) was notified (the “ Notification Letter ”) by The Nasdaq Stock Market, LLC (“ Nasdaq ”) that for the last thirty (30) consecutive business days, the Company’s Market Value of Listed Securities (“ MVLS ”) has been below the minimum requirement of $35 million for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2). The Notification Letter has no immediate effect on the listing or trading of the Company’s common stock and the common stock will continue to trade on the Nasdaq Capital Market under the symbol","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1869974/000149315224003091/0001493152-24-003091-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"market value"},{"label":"Rules","value":"5550(b)(2), 5810(c)(3)(C)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}